COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

This phase III trial studies how well axillary reverse mapping works in preventing lymphedema in patients with breast cancer undergoing axillary lymph node dissection. Axillary reverse mapping may help to preserve the lymph node drainage system around the breast so as to prevent lymphedema after surgery.

Research Base: Alliance for Clinical Trials in Oncology
NCT ID: NCT03927027
NCI Protocol Number: A221702
Status: Recruiting

For more information see



Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III

Trial Type

Supportive Care/Symptom Management/PROs

See a list of participating sites on